4.7 Article

The Role of Bacteria-Mitochondria Communication in the Activation of Neuronal Innate Immunity: Implications to Parkinson's Disease

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Footprints of a microbial toxin from the gut microbiome to mesencephalic mitochondria

A. Raquel Esteves et al.

Summary: This study aims to demonstrate that the effects of microbial toxin BMAA in the gut may trigger some cases of PD, and it can spread from the gut to the brain, leading to the development of PD. This finding is crucial for understanding the pathological progression of PD.
Article Cell Biology

Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function

Md Masud Alam et al.

Summary: Recent studies have shown that alpha-synuclein plays a crucial role in normal vertebrate physiology and is a critical mediator of inflammatory and immune responses. Neural cells are the sources of alpha-synuclein required for immune competence.

CELL REPORTS (2022)

Review Neurosciences

Lewy body disease or diseases with Lewy bodies?

Katerina Mensikova et al.

Summary: Alzheimer's disease is a neurodegenerative disease that causes cognitive and memory decline, as well as behavioral and emotional problems.

NPJ PARKINSONS DISEASE (2022)

Article Pharmacology & Pharmacy

Neuroinflammation Upregulated Neuronal Toll-Like Receptors 2 and 4 to Drive Synucleinopathy in Neurodegeneration

Lucia Yi-Ru Chung et al.

Summary: This study reveals that activated microglia-derived neuroinflammation induces neuronal TLR2/4-p38/JNK activation, disrupting autophagy and leading to accumulation of alpha-synuclein aggregates and neurite shortening. Targeting neuronal TLR2/4 pathway might provide a mechanistic-based therapy for neurodegenerative diseases such as Parkinson's disease.

FRONTIERS IN PHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

Early Forms of α-Synuclein Pathology Are Associated with Neuronal Complex I Deficiency in the Substantia Nigra of Individuals with Parkinson's Disease

Irene Hana Flones et al.

Summary: Early alpha-synuclein aggregation is associated with mitochondrial respiratory complex I (CI) deficiency in neurons of idiopathic Parkinson's disease (iPD), and there is selective loss of neurons affected by both pathologies.

BIOMOLECULES (2022)

Article Biochemistry & Molecular Biology

Restricting α-synuclein transport into mitochondria by inhibition of α-synuclein-VDAC complexation as a potential therapeutic target for Parkinson's disease treatment

Megha Rajendran et al.

Summary: This study discovered a small membrane-binding peptide, called HK2p, that inhibits the complex formation of alpha-synuclein (alpha Syn) with the voltage-dependent anion channel (VDAC). The peptide attenuates the mitochondrial toxicity caused by alpha Syn, suggesting a potential therapeutic avenue for Parkinson's disease and other synucleinopathies.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Review Clinical Neurology

Neurodegeneration and Neuroinflammation in Parkinson's Disease: a Self-Sustained Loop

G. Arena et al.

Summary: Neuroinflammation plays a significant role in the development of Parkinson's disease (PD), with potential involvement of mitochondrial dysfunction and impaired proteostasis. The cause of neuroinflammation in PD is still debated, but recent findings suggest the importance of intercellular communication and non-neuronal interactions in the disease. Aberrant activation of glial cells and other components of the immune system contribute to a vicious circle of neurodegeneration and neuroinflammation in PD. This review provides a summary of cellular alterations underlying neuroinflammation, including those induced by environmental factors and genetic background, and discusses potential clinical applications of immunobiomarkers and current therapeutic strategies for addressing inflammation in PD.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2022)

Review Immunology

The role of Toll-like receptors and neuroinflammation in Parkinson's disease

Arash Heidari et al.

Summary: Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the loss of dopaminergic neurons and aggregation of alpha-synuclein. Recent studies suggest that neuroinflammation may contribute to the loss of dopaminergic neurons in PD.

JOURNAL OF NEUROINFLAMMATION (2022)

Article Immunology

Hypothesis of a potential BrainBiota and its relation to CNS autoimmune inflammation

Maria L. Elkjaer et al.

Summary: Infectious agents have been implicated in the development of neurological diseases due to their interaction with genetic susceptibility and the environment. The role of bacteria in central nervous system autoimmunity has been highlighted by changes in the gut microbiota of patients with diseases such as Parkinson's, Alzheimer's, and multiple sclerosis, emphasizing the importance of the gut-brain axis. This article discusses the hypothesis of a brain microbiota, known as BrainBiota, which refers to bacteria living in symbiosis with brain cells. Evidence suggests the presence of various bacteria in the human brain, including morphological evidence, bacterial proteins, metabolites, transcripts, and mucosal-associated invariant T cells. The authors propose that these bacteria are integral to brain development, immune tolerance, and are directly linked to the gut microbiome. They also suggest that changes in the BrainBiota during brain diseases may be either a consequence or a cause of chronic inflammation, similar to the gut microbiota.

FRONTIERS IN IMMUNOLOGY (2022)

Review Immunology

Inflammation and immune dysfunction in Parkinson disease

Malu Gamez Tansey et al.

Summary: This review explores the role of an ageing immune system, host genetics, and exposure to environmental stressors in promoting the development of Parkinson's disease. It discusses the presence of neuroinflammation and alterations in immune cell populations as well as the potential contributions of viral or bacterial exposure, pesticides, and gut microbiota to disease pathogenesis.

NATURE REVIEWS IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

The Mitochondrial Ribosome: A World of Opportunities for Mitochondrial Dysfunction Toward Parkinson's Disease

Ana Mafalda Goncalves et al.

Summary: Recent studies have shown potential significance of mitochondrial ribosomal subunits in mitochondrial dysfunction in Parkinson's disease, however, the exact role of mitoribosomes remains largely unknown. Further research on the correlation between mitoribosome failure and PD pathology could lead to new clinical markers and therapeutic targets.

ANTIOXIDANTS & REDOX SIGNALING (2021)

Review Biochemistry & Molecular Biology

Mitochondria as a Cellular Hub in Infection and Inflammation

Pauline Andrieux et al.

Summary: Mitochondria are the energy powerhouse of the cell, playing essential roles in inflammation, pathogen response, and oxidative stress. Pathogens can exploit mitochondria to disrupt cellular functions by affecting oxidative phosphorylation mechanisms. Targeting mitochondria could be a promising therapeutic strategy for infectious and inflammatory diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Cell Biology

Cell Death and Inflammation: The Role of Mitochondria in Health and Disease

Anna Picca et al.

Summary: Mitochondria play a central role in cellular processes and maintaining organelle homeostasis is crucial for efficient mitochondrial function. Mechanisms of mitochondrial quality control, such as dynamics, biogenesis, proteostasis, and autophagy, safeguard organelle integrity and function. The crosstalk between autophagy and apoptosis plays a key role in regulating mtDNA release, cell fate, and inflammation. Interferon production during mtDNA-mediated inflammation may be utilized for the elimination of dying cells and promoting anti-tumor immunity.

CELLS (2021)

Review Neurosciences

Mitochondrial Function and Parkinson's Disease: From the Perspective of the Electron Transport Chain

Jeng-Lin Li et al.

Summary: Parkinson's disease is considered a mitochondrial disease and involves abnormalities in multiple genes related to mitochondrial functions, protein aggregation, lysosomal functions, etc. This diversity suggests that the pathogenesis of Parkinson's disease is complex and involves various aspects of cellular biology beyond just disorders in complex I of the electron transport chain.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)

Review Biochemistry & Molecular Biology

Macroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions

Joao Duarte Magalhaes et al.

Summary: Macroautophagy is a quality control mechanism that plays a crucial role in various human disorders, including neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's diseases. Evidence suggests that macroautophagy is involved in degrading protein aggregates and improving mitochondrial function in these disorders, indicating it as a potential therapeutic target.

BIOMEDICINES (2021)

Article Neurosciences

Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment

Yixuan Liang et al.

Summary: In this review, the potential roles of gut microbial dysbiosis in PD, particularly in terms of microbial metabolites and mitochondrial function, were highlighted. The impact of microbial metabolites on the central nervous system and mitochondrial dysfunction were discussed, along with the potential of targeting the gut microbiota as a therapeutic strategy for PD.

MOLECULAR NEUROBIOLOGY (2021)

Review Cell Biology

The neuromicrobiology of Parkinson's disease: A unifying theory

Mario F. Munoz-Pinto et al.

Summary: Parkinson's disease is a multifactorial disease with a close connection to microbes, and the imbalance of microbiota may impact the progression of the disease. Studies have found that microorganisms and mitochondria play important roles in the pathogenesis, facilitation, and aggravation of Parkinson's disease.

AGEING RESEARCH REVIEWS (2021)

Article Biochemistry & Molecular Biology

Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes

Hannah Scheiblich et al.

Summary: This study reveals that microglia form a cellular network to transfer and degrade alpha-synuclein fibrils, reducing inflammation and improving cell survival. This degradation strategy is compromised in cells carrying the LRRK2 G2019S mutation, highlighting a mechanism by which microglia enhance pathogenic alpha-synuclein clearance.
Review Immunology

Toll-Like Receptors: General Molecular and Structural Biology

Payam Behzadi et al.

Summary: TLRs play a crucial role in bridging innate and adaptive immune systems through activation by various molecular patterns. Their unique properties present opportunities for the development of ligand-drug discovery strategies.

JOURNAL OF IMMUNOLOGY RESEARCH (2021)

Article Neurosciences

Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway

Jae-Hyeon Park et al.

MOLECULAR NEURODEGENERATION (2020)

Article Multidisciplinary Sciences

The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration

Anne-Laure Mahul-Mellier et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Multidisciplinary Sciences

Microglia clear neuron-released a-synuclein via selective autophagy and prevent neurodegeneration

Insup Choi et al.

NATURE COMMUNICATIONS (2020)

Review Immunology

Cerebral sterile inflammation in neurodegenerative diseases

Kento Otani et al.

INFLAMMATION AND REGENERATION (2020)

Article Biochemistry & Molecular Biology

Cytochrome c can be released into extracellular space and modulate functions of human astrocytes in a toll-like receptor 4-dependent manner

Tyler J. Wenzel et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2019)

Article Immunology

Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease

Chin-Hsien Lin et al.

JOURNAL OF NEUROINFLAMMATION (2019)

Review Neurosciences

Mechanisms of Pathogen Invasion into the Central Nervous System

Matthew D. Cain et al.

NEURON (2019)

Review Cell Biology

Innate immunity and tolerance toward mitochondria

Anthony Rongvaux

MITOCHONDRION (2018)

Review Physiology

The Microbiome-Mitochondria Dance in Prodromal Parkinson's Disease

Sandra M. Cardoso et al.

FRONTIERS IN PHYSIOLOGY (2018)

Review Immunology

Mitochondria: An Organelle of Bacterial Origin Controlling Inflammation

Alain Meyer et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Multidisciplinary Sciences

Deep mitochondrial origin outside the sampled alphaproteobacteria

Joran Martijn et al.

NATURE (2018)

Article Clinical Neurology

Peripheral blood inflammatory markers in early Parkinson's disease

Ryul Kim et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2018)

Article Immunology

Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration

Heather M. Wilkins et al.

FRONTIERS IN IMMUNOLOGY (2017)

Review Biochemistry & Molecular Biology

NF-kappa B signaling in inflammation

Ting Liu et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)

Review Biochemistry & Molecular Biology

The Origin and Diversification of Mitochondria

Andrew J. Roger et al.

CURRENT BIOLOGY (2017)

Article Biochemistry & Molecular Biology

The novel mechanism of rotenone-induced α-synuclein phosphorylation via reduced protein phosphatase 2A activity

Yi Wang et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)

Article Medicine, General & Internal

Parkinson's disease

Lorraine V. Kalia et al.

LANCET (2015)

Article Neurosciences

The Impact of Mitochondrial Fusion and Fission Modulation in Sporadic Parkinson's Disease

Daniel Santos et al.

MOLECULAR NEUROBIOLOGY (2015)

Article Biochemistry & Molecular Biology

Mitochondrial metabolism in Parkinsons disease impairs quality control autophagy by hampering microtubule-dependent traffic

Daniela M. Arduino et al.

HUMAN MOLECULAR GENETICS (2012)

Article Multidisciplinary Sciences

Expression of Toll-Like Receptors in the Developing Brain

David Kaul et al.

PLOS ONE (2012)

Article Pharmacology & Pharmacy

The Mitochondrial Cascade Hypothesis for Parkinsons Disease

Sandra M. Cardoso

CURRENT PHARMACEUTICAL DESIGN (2011)

Article Biochemistry & Molecular Biology

Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy

Matthew E. Gegg et al.

HUMAN MOLECULAR GENETICS (2010)

Article Biology

The α-proteobacteria: the Darwin finches of the bacterial world

Thijs J. G. Ettema et al.

BIOLOGY LETTERS (2009)

Article Clinical Neurology

Therapeutic approaches to inflammation in neurodegenerative disease

Andis Klegeris et al.

CURRENT OPINION IN NEUROLOGY (2007)

Article Multidisciplinary Sciences

Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway

S Lehnardt et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)